Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 11/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.54 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.54 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | REN | P00797 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10896161 | 0.96 | ACE (0.57) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10793285 | 0.95 | ACE (0.57) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10798072 | 0.95 | ACE (0.57) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10793279 | 0.95 | ACE (0.57) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10793326 | 0.95 | ACE (0.57) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10914216 | 0.94 | ACE (0.59) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10894022 | 0.94 | ACE (0.59) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10791439 | 0.93 | ACE (0.58) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10796387 | 0.93 | ACE (0.58) | ACEABCB11AGTR2PDE3ATDP1 | |
| SCHEMBL10791449 | 0.93 | ACE (0.58) | ACEABCB11AGTR2PDE3ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4587050-A | Substituted enantholactam derivatives as antihypertensives | MERCK & CO., INC. (US) | 1986-05-06 | — | — | US | disclosed |
| EP-0046289-B1 | SUBSTITUTED ENANTHOLACTAM DERIVATIVES AS ANTIHYPERTENSIVES, A PROCESS FOR PREPARING AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND INTERMEDIATES | MERCK & CO. INC. (US) | 1985-11-27 | — | — | EP | disclosed |
| EP-0046289-A2 | Substituted enantholactam derivatives as antihypertensives, a process for preparing and a pharmaceutical composition containing them, and intermediates | MERCK & CO. INC. (US) | 1982-02-24 | — | — | EP | disclosed |